One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
What Really Happened During the Massive SARS-CoV-2 Omicron Wave in China?
John P. A. Ioannidis, MD, DSc1,2,3; Francesco Zonta, PhD4; Michael Levitt, PhD5
doi : 10.1001/jamainternmed.2023.1547
July 2023, Vol 183, No. 7, Pages 632-748
Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs
Autumn D. Zuckerman, PharmD1; Megan P. Schneider, PharmD1; Stacie B. Dusetzina, PhD2
Medicare Skilled Nursing Facility Use and Spending Before and After Introduction of the Public Health Emergency Waiver During the COVID-19 Pandemic
Agne Ulyte, MD, PhD1; R. J. Waken, PhD2; Arnold M. Epstein, MD, MA3,4; E. John Orav, PhD4; Michael L. Barnett, MD, MS3,4; Karen E. Joynt Maddox, MD, MPH2,5; David C. Grabowski, PhD1
doi : 10.1001/jamainternmed.2023.0770
Importance In response to the COVID-19 pandemic, Medicare introduced a public health emergency (PHE) waiver in March 2020, removing a 3-day hospitalization requirement before fee-for-service beneficiaries could receive skilled nursing facility (SNF) care benefits.
Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis
Songqiao Liu, MD, PhD1; Chen Yao, PhD2; Jianfeng Xie, MD, PhD1; Hong Liu, MD, PhD3; Hongliang Wang, MD, PhD4; Zhaofen Lin, MD5; Bingyu Qin, MD6; Difen Wang, MD7; Weihua Lu, MD8; Xiaochun Ma, MD, PhD9; Yan Liu, MD10; Ling Liu, MD,, PhD1; Chi Zhang, MD, PhD11; Lei Xu, MD, PhD12; Ruiqiang Zheng, MD13; Feihu Zhou, MD, PhD14; Zhongmin Liu, MD15; Guoqiang Zhang, MD, PhD16; Lixin Zhou, MD, PhD17; Jian Liu, MD, PhD18; Aihua Fei, MD19; Guoxiu Zhang, MD20; Yimin Zhu, MD, PhD21; Kejian Qian, MD, PhD22; Ruilan Wang, MD, PhD23; Yafeng Liang, MD24; Meili Duan, MD, PhD25; Dawei Wu, MD26; Rongqing Sun, MD27; Ying Wang, MD, PhD28; Xijing Zhang, MD, PhD29; Quan Cao, MD, PhD30; Mingshi Yang, MD, PhD31; Minggen Jin, MD, PhD32; Yan Song, MD, PhD33; Ling Huang, MD, PhD34; Fachun Zhou, MD35; Dechang Chen, MD, PhD36; Qun Liang, MD, PhD37; Chuanyun Qian, MD, PhD38; Zhongzhi Tang, MD39; Zhong Zhang, MD, PhD40; Qiming Feng, MD, PhD41; Zhiyong Peng, MD, PhD42; Renhua Sun, MD43; Zhenju Song, MD, PhD44; Yunbo Sun, MD45; Yanfen Chai, MD46; Lihua Zhou, MD, PhD47; Chen Cheng, MD, PhD48; Li Li, MD, PhD49; Xiaoyan Yan, MD, PhD2; Junhua Zhang, MD, PhD50; Yingzi Huang, MD, PhD1; Fengmei Guo, MD, PhD1; Chuan Li, MD, PhD48; Yi Yang, MD, PhD1; Hongcai Shang, MD, PhD10; Haibo Qiu, MD, PhD1; for the EXIT-SEP Investigators
doi : 10.1001/jamainternmed.2023.0780
Importance Previous research has suggested that Xuebijing injection (XBJ), an herbal-based intravenous preparation, may reduce mortality among patients with sepsis.
Effects of a Multimodal Transitional Care Intervention in Patients at High Risk of Readmission
Jacques Donzé, MD, MSc1,2,3,4; Gregor John, MD1,5,6; Daniel Genné, MD7; Marco Mancinetti, MD, MME8,9; Alexandre Gouveia, MD10; Marie Méan, MD11; Lukas Bütikofer, PhD12; Drahomir Aujesky, MD, MSc13; Jeffrey Schnipper, MD, MSc4
doi : 10.1001/jamainternmed.2023.0791
Importance Hospital readmissions are frequent, costly, and sometimes preventable. Although these issues have been well publicized and incentives to reduce them introduced, the best interventions for reducing readmissions remain unclear.
Changes in Prescription Drug and Health Care Use Over 9 Years After the Large Drug Price Increase for Colchicine
Dan P. Ly, MD, PhD, MPP1,2; Mia A. Giuriato, BBA, MA3; Zirui Song, MD, PhD3,4,5
doi : 10.1001/jamainternmed.2023.0898
Importance Prescription drug prices are a leading concern among patients and policy makers. There have been large and sharp price increases for some drugs, but the long-term implications of large drug price increases remain poorly understood.
Significant Incidental Findings in the National Lung Screening Trial
Ilana F. Gareen, PhD1,2; Roee Gutman, PhD2,3; JoRean Sicks, MS2; Tina D. Tailor, MD4; Richard M. Hoffman, MD, MPH5; Amal N. Trivedi, MD, MPH6,7; Efren Flores, MD8; Ellen Underwood, MS2; Jerson Cochancela, MS3; Caroline Chiles, MD9
doi : 10.1001/jamainternmed.2023.1116
Importance Low-dose computed tomography (LDCT) lung screening has been shown to reduce lung cancer mortality. Significant incidental findings (SIFs) have been widely reported in patients undergoing LDCT lung screening. However, the exact nature of these SIF findings has not been described.
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers
William B. Feldman, MD, DPhil, MPH1,2,3; Jerry Avorn, MD1,3; Aaron S. Kesselheim, MD, JD, MPH1,3; Joshua J. Gagne, PharmD, ScD1,3,4
doi : 10.1001/jamainternmed.2023.1245
Importance Clinical guidelines on chronic obstructive pulmonary disease (COPD) recommend inhalers containing long-acting muscarinic antagonists (LAMAs) and long-acting β-agonists (LABAs) over inhalers containing inhaled corticosteroids (ICSs) and LABAs. However, data from randomized clinical trials comparing these combination inhalers (LAMA-LABAs vs ICS-LABAs) have been conflicting and raised concerns of generalizability.
Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women’s Health Initiative Study
Carolyn J. Crandall, MD, MS, MACP1; Joseph C. Larson, MS2; John T. Schousboe, MD, PhD3; JoAnn E. Manson, MD, DrPH4; Nelson B. Watts, MD5; John A. Robbins, MD6; Peter Schnatz, DO7,8; Rami Nassir, PhD9; Aladdin H. Shadyab, PhD10; Karen C. Johnson, MD, MPH11; Jane A. Cauley, DrPH12; Kristine E. Ensrud, MD, MPH13
doi : 10.1001/jamainternmed.2023.1253
Importance The best approach to identify younger postmenopausal women for osteoporosis screening is uncertain. The Fracture Risk Assessment Tool (FRAX), which includes self-identified racial and ethnic information, and the Osteoporosis Self-assessment Tool (OST), which does not, are risk assessment tools recommended by US Preventive Services Task Force guidelines to identify candidates for bone mineral density (BMD) testing in this age group.
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
Deborah J. Wexler, MD, MSc1; Ian H. de Boer, MD2; Alokananda Ghosh, MD, PhD3; Naji Younes, PhD3; Ionut Bebu, PhD3; Silvio E. Inzucchi, MD4; Janet B. McGill, MD5; Sunder Mudaliar, MD6; David Schade, MD7; Michael W. Steffes, MD, PhD8; William V. Tamborlane, MD9; Meng H. Tan, MD10; Faramarz Ismail-Beigi, MD, PhD11; for the GRADE Research Group
doi : 10.1001/jamainternmed.2023.1487
Importance Type 2 diabetes (T2D) is the leading cause of kidney disease in the US. It is not known whether glucose-lowering medications differentially affect kidney function.
Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults
Timothy S. Anderson, MD, MAS1,2,3; Shoshana J. Herzig, MD, MPH1,2; Bocheng Jing, MS3,4; W. John Boscardin, PhD3,4,5; Kathy Fung, MS3,4; Edward R. Marcantonio, MD, SM1,2; Michael A. Steinman, MD3,4
doi : 10.1001/jamainternmed.2023.1667
Importance Asymptomatic blood pressure (BP) elevations are common in hospitalized older adults, and widespread heterogeneity in the clinical management of elevated inpatient BPs exists.
A Brief History of the 3-Day Hospital Stay Rule
Vincent Mor, PhD1
Xuebijing Injection for the Treatment of Sepsis
Ellis F. Unger, MD1; David B. Clissold, JD1
The Disappointing Impact of Interventions to Prevent Hospital Readmissions
Robert M. Wachter, MD1
Estimating Changes in Medicare Part D and Commercial Insurer Insulin Spending Amid Planned State-Led Biosimilar Insulin Production in California
Kelly E. Anderson, PhD, MPP1; Andrew Xuan, MPH2; Gerard F. Anderson, PhD2; Mariana P. Socal, MD, PhD, MPP2
Availability of Unique Device Identifiers for Class I Medical Device Recalls From 2018 to 2022
Maryam Mooghali, MD, MSc1,2; Joseph S. Ross, MD, MHS1,2,3; Kushal T. Kadakia, MSc4; Sanket S. Dhruva, MD, MHS5,6
Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US
Shelley A. Jazowski, PhD, MPH1; Avi U. Vaidya, MPH1; Julie M. Donohue, PhD2; Stacie B. Dusetzina, PhD1,3; Rachel E. Sachs, JD, MPH4
Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions
Catherine L. Auriemma, MD, MS1,2,3; Maayra I.  Butt, MS1; Jasmine A. Silvestri, MPH1; Scott D. Halpern, MD, PhD1,2,3; Katherine R. Courtright, MD, MS1,2,3
Red Flag on Electrocardiogram Findings in a Patient With Lung Cancer
Nan Zhang, BS1; Siyao Cheng, MS2; Xuhong Geng, MD2
“Narrow-Wide-Narrow� QRS Complex Tachycardia—Beware the Smartwatch Monsters
Vincenzo Russo, MD, PhD1; Antonia Ascrizzi, MD1; Alfredo Mauriello, MD1
Wide Complex Tachycardia Observed During Pregnancy
Michael P. Lavelle, MD1; John P. Morrow, MD1; James A. Reiffel, MD1
A Pregnant Patient With Narrow QRS Tachycardia
Kapil Rajendran, MD, DM1; Vinayakumar Desabandhu, MD, DM1; Pranay Ghanshyam Jambhulkar, MD, DM1
Fact or Artifact in Inferior ST Elevation—Avoiding Misdiagnosis and Missed Diagnosis
Zhao-Wei Yin, MD1; Pan Li, MD1; WenBiao Chen, PhD2
Underreported Sexual Harassment Gives False Impression That the Situation Is Better Than It Is
Amy Joy Houtrow, MD, PhD, MPH1
Underreported Sexual Harassment Gives False Impression That the Situation Is Better Than It Is—Reply
Elizabeth M. Viglianti, MD, MPH, MSc1; Lisa M. Meeks, PhD2; Andrea L. Oliverio, MD, MSc3
Changes in Physician Work Hours and Implications for Workforce Capacity, 2001 to 2021
Yi-Jui Chiu, MD1; Kuan-Yu Chiang, MD1; Nin-Chieh Hsu, MD, PhD2
Changes in Physician Work Hours and Implications for Workforce Capacity, 2001 to 2021—Reply
Anna L. Goldman, MD, MPA, MPH1; Michael L. Barnett, MD, MS2,3
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles
Steven A. Wisel, MD1; Justin A. Steggerda, MD1; Irene K. Kim, MD1
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles
Larry A. Weinrauch, MD1; John A. D’Elia, MD1
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles—Reply
Xingxing S. Cheng, MD, MS1
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads
Mazen M. Kawji, MD1,2
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads
Ding Peng, MD1; Xiulian Li, MD1; Guojun Zhao, PhD1
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads—Reply
Li Wang, MD1; Caiyun Duan, BS1; Lan Ma, MD, MS1
Aiming to Improve Racial and Ethnic Representation in COVID-19 Trials
Frederick Green, MBBS1; Zeynep Ersoy Guller, MD1; Suhail Aslam, BMBCh2
What Really Happened During the Massive SARS-CoV-2 Omicron Wave in China?
John P. A. Ioannidis, MD, DSc1,2,3; Francesco Zonta, PhD4; Michael Levitt, PhD5
doi : 10.1001/jamainternmed.2023.1547
July 2023, Vol 183, No. 7, Pages 632-748
Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs
Autumn D. Zuckerman, PharmD1; Megan P. Schneider, PharmD1; Stacie B. Dusetzina, PhD2
Medicare Skilled Nursing Facility Use and Spending Before and After Introduction of the Public Health Emergency Waiver During the COVID-19 Pandemic
Agne Ulyte, MD, PhD1; R. J. Waken, PhD2; Arnold M. Epstein, MD, MA3,4; E. John Orav, PhD4; Michael L. Barnett, MD, MS3,4; Karen E. Joynt Maddox, MD, MPH2,5; David C. Grabowski, PhD1
doi : 10.1001/jamainternmed.2023.0770
Importance In response to the COVID-19 pandemic, Medicare introduced a public health emergency (PHE) waiver in March 2020, removing a 3-day hospitalization requirement before fee-for-service beneficiaries could receive skilled nursing facility (SNF) care benefits.
Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis
Songqiao Liu, MD, PhD1; Chen Yao, PhD2; Jianfeng Xie, MD, PhD1; Hong Liu, MD, PhD3; Hongliang Wang, MD, PhD4; Zhaofen Lin, MD5; Bingyu Qin, MD6; Difen Wang, MD7; Weihua Lu, MD8; Xiaochun Ma, MD, PhD9; Yan Liu, MD10; Ling Liu, MD,, PhD1; Chi Zhang, MD, PhD11; Lei Xu, MD, PhD12; Ruiqiang Zheng, MD13; Feihu Zhou, MD, PhD14; Zhongmin Liu, MD15; Guoqiang Zhang, MD, PhD16; Lixin Zhou, MD, PhD17; Jian Liu, MD, PhD18; Aihua Fei, MD19; Guoxiu Zhang, MD20; Yimin Zhu, MD, PhD21; Kejian Qian, MD, PhD22; Ruilan Wang, MD, PhD23; Yafeng Liang, MD24; Meili Duan, MD, PhD25; Dawei Wu, MD26; Rongqing Sun, MD27; Ying Wang, MD, PhD28; Xijing Zhang, MD, PhD29; Quan Cao, MD, PhD30; Mingshi Yang, MD, PhD31; Minggen Jin, MD, PhD32; Yan Song, MD, PhD33; Ling Huang, MD, PhD34; Fachun Zhou, MD35; Dechang Chen, MD, PhD36; Qun Liang, MD, PhD37; Chuanyun Qian, MD, PhD38; Zhongzhi Tang, MD39; Zhong Zhang, MD, PhD40; Qiming Feng, MD, PhD41; Zhiyong Peng, MD, PhD42; Renhua Sun, MD43; Zhenju Song, MD, PhD44; Yunbo Sun, MD45; Yanfen Chai, MD46; Lihua Zhou, MD, PhD47; Chen Cheng, MD, PhD48; Li Li, MD, PhD49; Xiaoyan Yan, MD, PhD2; Junhua Zhang, MD, PhD50; Yingzi Huang, MD, PhD1; Fengmei Guo, MD, PhD1; Chuan Li, MD, PhD48; Yi Yang, MD, PhD1; Hongcai Shang, MD, PhD10; Haibo Qiu, MD, PhD1; for the EXIT-SEP Investigators
doi : 10.1001/jamainternmed.2023.0780
Importance Previous research has suggested that Xuebijing injection (XBJ), an herbal-based intravenous preparation, may reduce mortality among patients with sepsis.
Effects of a Multimodal Transitional Care Intervention in Patients at High Risk of Readmission
Jacques Donzé, MD, MSc1,2,3,4; Gregor John, MD1,5,6; Daniel Genné, MD7; Marco Mancinetti, MD, MME8,9; Alexandre Gouveia, MD10; Marie Méan, MD11; Lukas Bütikofer, PhD12; Drahomir Aujesky, MD, MSc13; Jeffrey Schnipper, MD, MSc4
doi : 10.1001/jamainternmed.2023.0791
Importance Hospital readmissions are frequent, costly, and sometimes preventable. Although these issues have been well publicized and incentives to reduce them introduced, the best interventions for reducing readmissions remain unclear.
Changes in Prescription Drug and Health Care Use Over 9 Years After the Large Drug Price Increase for Colchicine
Dan P. Ly, MD, PhD, MPP1,2; Mia A. Giuriato, BBA, MA3; Zirui Song, MD, PhD3,4,5
doi : 10.1001/jamainternmed.2023.0898
Importance Prescription drug prices are a leading concern among patients and policy makers. There have been large and sharp price increases for some drugs, but the long-term implications of large drug price increases remain poorly understood.
Significant Incidental Findings in the National Lung Screening Trial
Ilana F. Gareen, PhD1,2; Roee Gutman, PhD2,3; JoRean Sicks, MS2; Tina D. Tailor, MD4; Richard M. Hoffman, MD, MPH5; Amal N. Trivedi, MD, MPH6,7; Efren Flores, MD8; Ellen Underwood, MS2; Jerson Cochancela, MS3; Caroline Chiles, MD9
doi : 10.1001/jamainternmed.2023.1116
Importance Low-dose computed tomography (LDCT) lung screening has been shown to reduce lung cancer mortality. Significant incidental findings (SIFs) have been widely reported in patients undergoing LDCT lung screening. However, the exact nature of these SIF findings has not been described.
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers
William B. Feldman, MD, DPhil, MPH1,2,3; Jerry Avorn, MD1,3; Aaron S. Kesselheim, MD, JD, MPH1,3; Joshua J. Gagne, PharmD, ScD1,3,4
doi : 10.1001/jamainternmed.2023.1245
Importance Clinical guidelines on chronic obstructive pulmonary disease (COPD) recommend inhalers containing long-acting muscarinic antagonists (LAMAs) and long-acting β-agonists (LABAs) over inhalers containing inhaled corticosteroids (ICSs) and LABAs. However, data from randomized clinical trials comparing these combination inhalers (LAMA-LABAs vs ICS-LABAs) have been conflicting and raised concerns of generalizability.
Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women’s Health Initiative Study
Carolyn J. Crandall, MD, MS, MACP1; Joseph C. Larson, MS2; John T. Schousboe, MD, PhD3; JoAnn E. Manson, MD, DrPH4; Nelson B. Watts, MD5; John A. Robbins, MD6; Peter Schnatz, DO7,8; Rami Nassir, PhD9; Aladdin H. Shadyab, PhD10; Karen C. Johnson, MD, MPH11; Jane A. Cauley, DrPH12; Kristine E. Ensrud, MD, MPH13
doi : 10.1001/jamainternmed.2023.1253
Importance The best approach to identify younger postmenopausal women for osteoporosis screening is uncertain. The Fracture Risk Assessment Tool (FRAX), which includes self-identified racial and ethnic information, and the Osteoporosis Self-assessment Tool (OST), which does not, are risk assessment tools recommended by US Preventive Services Task Force guidelines to identify candidates for bone mineral density (BMD) testing in this age group.
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
Deborah J. Wexler, MD, MSc1; Ian H. de Boer, MD2; Alokananda Ghosh, MD, PhD3; Naji Younes, PhD3; Ionut Bebu, PhD3; Silvio E. Inzucchi, MD4; Janet B. McGill, MD5; Sunder Mudaliar, MD6; David Schade, MD7; Michael W. Steffes, MD, PhD8; William V. Tamborlane, MD9; Meng H. Tan, MD10; Faramarz Ismail-Beigi, MD, PhD11; for the GRADE Research Group
doi : 10.1001/jamainternmed.2023.1487
Importance Type 2 diabetes (T2D) is the leading cause of kidney disease in the US. It is not known whether glucose-lowering medications differentially affect kidney function.
Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults
Timothy S. Anderson, MD, MAS1,2,3; Shoshana J. Herzig, MD, MPH1,2; Bocheng Jing, MS3,4; W. John Boscardin, PhD3,4,5; Kathy Fung, MS3,4; Edward R. Marcantonio, MD, SM1,2; Michael A. Steinman, MD3,4
doi : 10.1001/jamainternmed.2023.1667
Importance Asymptomatic blood pressure (BP) elevations are common in hospitalized older adults, and widespread heterogeneity in the clinical management of elevated inpatient BPs exists.
A Brief History of the 3-Day Hospital Stay Rule
Vincent Mor, PhD1
Xuebijing Injection for the Treatment of Sepsis
Ellis F. Unger, MD1; David B. Clissold, JD1
The Disappointing Impact of Interventions to Prevent Hospital Readmissions
Robert M. Wachter, MD1
Estimating Changes in Medicare Part D and Commercial Insurer Insulin Spending Amid Planned State-Led Biosimilar Insulin Production in California
Kelly E. Anderson, PhD, MPP1; Andrew Xuan, MPH2; Gerard F. Anderson, PhD2; Mariana P. Socal, MD, PhD, MPP2
Availability of Unique Device Identifiers for Class I Medical Device Recalls From 2018 to 2022
Maryam Mooghali, MD, MSc1,2; Joseph S. Ross, MD, MHS1,2,3; Kushal T. Kadakia, MSc4; Sanket S. Dhruva, MD, MHS5,6
Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US
Shelley A. Jazowski, PhD, MPH1; Avi U. Vaidya, MPH1; Julie M. Donohue, PhD2; Stacie B. Dusetzina, PhD1,3; Rachel E. Sachs, JD, MPH4
Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions
Catherine L. Auriemma, MD, MS1,2,3; Maayra I.  Butt, MS1; Jasmine A. Silvestri, MPH1; Scott D. Halpern, MD, PhD1,2,3; Katherine R. Courtright, MD, MS1,2,3
Red Flag on Electrocardiogram Findings in a Patient With Lung Cancer
Nan Zhang, BS1; Siyao Cheng, MS2; Xuhong Geng, MD2
“Narrow-Wide-Narrow� QRS Complex Tachycardia—Beware the Smartwatch Monsters
Vincenzo Russo, MD, PhD1; Antonia Ascrizzi, MD1; Alfredo Mauriello, MD1
Wide Complex Tachycardia Observed During Pregnancy
Michael P. Lavelle, MD1; John P. Morrow, MD1; James A. Reiffel, MD1
A Pregnant Patient With Narrow QRS Tachycardia
Kapil Rajendran, MD, DM1; Vinayakumar Desabandhu, MD, DM1; Pranay Ghanshyam Jambhulkar, MD, DM1
Fact or Artifact in Inferior ST Elevation—Avoiding Misdiagnosis and Missed Diagnosis
Zhao-Wei Yin, MD1; Pan Li, MD1; WenBiao Chen, PhD2
Underreported Sexual Harassment Gives False Impression That the Situation Is Better Than It Is
Amy Joy Houtrow, MD, PhD, MPH1
Underreported Sexual Harassment Gives False Impression That the Situation Is Better Than It Is—Reply
Elizabeth M. Viglianti, MD, MPH, MSc1; Lisa M. Meeks, PhD2; Andrea L. Oliverio, MD, MSc3
Changes in Physician Work Hours and Implications for Workforce Capacity, 2001 to 2021
Yi-Jui Chiu, MD1; Kuan-Yu Chiang, MD1; Nin-Chieh Hsu, MD, PhD2
Changes in Physician Work Hours and Implications for Workforce Capacity, 2001 to 2021—Reply
Anna L. Goldman, MD, MPA, MPH1; Michael L. Barnett, MD, MS2,3
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles
Steven A. Wisel, MD1; Justin A. Steggerda, MD1; Irene K. Kim, MD1
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles
Larry A. Weinrauch, MD1; John A. D’Elia, MD1
Preoperative Evaluations Before Transplantation—Essential Tools, Not Obstacles—Reply
Xingxing S. Cheng, MD, MS1
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads
Mazen M. Kawji, MD1,2
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads
Ding Peng, MD1; Xiulian Li, MD1; Guojun Zhao, PhD1
Avoiding and Identifying Reversal of Left Arm and Left Leg Leads—Reply
Li Wang, MD1; Caiyun Duan, BS1; Lan Ma, MD, MS1
Aiming to Improve Racial and Ethnic Representation in COVID-19 Trials
Frederick Green, MBBS1; Zeynep Ersoy Guller, MD1; Suhail Aslam, BMBCh2
